Skip to Content

WATSON 3449 20 mg (Morphine Sulfate Extended Release 20 mg)

Pill with imprint WATSON 3449 20 mg is Yellow & White, Capsule-shape and has been identified as Morphine Sulfate Extended Release 20 mg. It is supplied by Watson Laboratories, Inc..

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3449 20 mg

Morphine sulfate extended release 20 mg WATSON 3449 20 mg

Morphine Sulfate Extended Release

Imprint
WATSON 3449 20 mg
Strength
20 mg
Color
Yellow & White
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3449
Inactive Ingredients
corn starch, diethyl phthalate, ethylcelluloses, polyethylene glycol 6000, sucrose, povidone k30, magnesium silicate, ferric oxide black, gelatin, propylene glycol, titanium dioxide, D&C Yellow No. 10, hypromellose 2910 (5 mPa.s), methacrylic acid - ethyl acrylate copolymer (1:1) type a

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.